This is a firm-fixed-price delivery order awarded by the Food and Drug Administration (FDA) to Ansys Inc., a provider of engineering simulation software and services. The contract, valued at $121,691.93, is for the provision of computational fluid dynamics (CFD) modeling software and does not have a set-aside designation. The contract was issued under Ansys' General Services Administration (GSA) Federal Supply Schedule IT-70 contract, a $558 million IDIQ vehicle that enables federal agencies...
This definitive, firm fixed-price contract was awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to CFD Research Corporation, a for-profit organization, to develop a multiscale computational framework for assessing the bioequivalence of orally inhaled drugs. The $499,761 contract does not have a set-aside designation. The original solicitation was a Broad Agency Announcement (BAA) seeking research and development to advance FDA's mission of protecting...
This is a $950,450 cost-plus-fixed-fee contract awarded by the Food and Drug Administration (FDA) to CFD Research Corporation, a small business, to develop a Computational Fluid Dynamics (CFD)-Physiologically-Based Pharmacokinetic (PBPK) framework to support the bioequivalence evaluation of ophthalmic drugs. The contract is part of the FDA's Broad Agency Announcement (BAA) for research and development to advance regulatory science and innovation, with no set-aside used. CFD Research...
This is a firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Flownamics Analytical Instruments Inc., a for-profit manufacturer of goods. The $45,388.93 contract is for CDER FLOWNAMICS OPC SOFTWARE, with an ultimate completion date of August 31, 2025. Flownamics is a small business that has previously held other FDA contracts, some of which were set aside for small businesses. This purchase order is not associated with a larger contract vehicle, and there is no...
The U.S. Department of Health and Human Services Food and Drug Administration awarded a delivery order to Ansys Inc., a provider of engineering simulation software, for a "Shared Multiphysics Computational Modeling Platform." The $137,297.23 firm-fixed-price contract, which does not have a set-aside designation, was issued under Ansys' existing Multiple Award Schedule (MAS) contract with the General Services Administration. This 5-year, $558 million IDIQ vehicle allows federal agencies...
<p>This is a firm-fixed-price purchase order contract awarded by the National Air and Space Intelligence Center (NASIC), a defense agency, to Analysis & Design Application CO. LTD. (doing business as Cd-Adapco) for the procurement of STAR-CCM+ software. The contract has a ceiling value of $75,190 and a period of performance that ends on September 27, 2016. The contract was awarded on September 28, 2015 and does not have a set-aside designation.</p>
This is a $165,457 firm-fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to Global Life Sciences Solutions USA LLC, a for-profit limited liability company. The contract is for the delivery of mechanistic chromatography modeling software. This award is not associated with a set-aside program. Through this contract, the FDA is acquiring scientific software to support its biomedical research and laboratory operations. Global Life Sciences Solutions USA LLC is...
This contract award to Ansys Inc. is for the delivery of the company's ANSYS MULTIPHYSICS COMPUTATIONAL MODELING PLATFORM software to the Department of Health and Human Services Food and Drug Administration. The $110,963.44 firm-fixed-price contract was issued as a delivery order under Ansys Inc.'s Information Technology Schedule 70 (IT-70) master contract with the General Services Administration. This larger indefinite-delivery/indefinite-quantity vehicle allows Ansys to provide a range of...
The U.S. Food and Drug Administration (FDA) awarded a $354,137.95 Firm Fixed Price purchase order to Altair Engineering Inc. for a license of EDEM or an equivalent Discrete Element Method (DEM) modeling and simulation software. The software will be used to support the FDA's research and evaluation processes in drug development and related scientific applications. The contract has a base year and four additional one-year option periods, spanning from June 8, 2025, to June 7, 2030. The procurement...
This is a $407,223.96 firm-fixed-price purchase order awarded by the Department of Health and Human Services Food and Drug Administration (HHS FDA) to Ansys Inc., a for-profit engineering simulation software provider, for the renewal of ANSYS software licenses. The award does not have a set-aside designation. Through past federal contracts, Ansys has provided a range of computational modeling and simulation software solutions to support engineering analysis, research, and testing programs across...